Newsbenzinga
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Deals
· Published
Article summary
Johnson & Johnson expands its biotech pipeline with Firefly Bio acquisition and a strategic partnership with Sail Biomedicines.
An excerpt from the original article.
Comments —
Loading comments…